Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer

Annals of Surgery

Volumn 241, Issue 6, 2005, Pages 1005-1015

  Martin II, Robert C G ^a   Chagpar, Anees ^a   Scoggins, Charles R ^a   Edwards, Michael J ^b   Hagendoorn, Lee ^c   Stromberg, Arnold J ^c   McMasters, Kelly M ^a,d   Copeland III, Edward M ^e   Urist, Marshall M ^e   Bland, Kirby I ^e   Hunt, Kelly K ^e  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Advertek Inc   (United States)

^d UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISOSULFAN BLUE; RADIOACTIVE MATERIAL; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CANCER; CANCER INVASION; CANCER STAGING; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIVARIATE ANALYSIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; CLINICAL COMPETENCE; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 21144442934     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000165200.32722.02     Document Type: Conference Paper

References (51)

1. Kelley MC, Hansen N, McMasters KM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg. 2004;188: 49-61.
2. McMasters KM, Wong SL, Chao C, et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg. 2001;234:292-299.
3. McMasters KM, Giuliano AE, Ross MI, et al. Sentinel-lymph-node biopsy for breast cancer: not yet the standard of care. N Engl J Med. 1998;339:990-995.
4. Derossis AM, Fey J, Yeung H, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg. 2001;193:473-478.
5. Chagpar A, Martin RC III, Chao C, et al. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg. 2004;139:614-618.
6. Chao C, Wong SL, Woo C, et al. Reliable lymphatic drainage to axillary sentinel lymph nodes regardless of tumor location within the breast. Am J Surg. 2001;182:307-311.
7. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med. 1998;339:941-946.
8. Tafra L, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg. 2001;233:51-59.
9. Wong SL, Edwards MJ, Chao C, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg. 2001;192:684-689.
10. Kennedy RJ, Kollias J, Gill PG, et al. Removal of two sentinel nodes accurately stages the axilla in breast cancer. Br J Surg. 2003;90:1349-1353.
11. Duncan M, Cech A, Wechter D, et al. Criteria for establishing the adequacy of a sentinel lymphadenectomy. Am J Surg. 2004;187:639-642.
12. Martin RC, Fey J, Yeung H, et al. Highest isotope count does not predict sentinel node positivity in all breast cancer patients. Ann Surg Oncol. 2001;8:592-597.
13. Chua B, Olivotto IA, Donald JC, et al. Outcomes of sentinel node biopsy for breast cancer in British Columbia, 1996 to 2001. Am J Surg. 2003; 185:118-126.
14. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818-1822.
15. Veronesi U, Paganelli G, Galimberi V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes. Lancet. 1997;349:1864-1867.
16. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg. 1998;186:275-283.
17. Feldman SM, Krag DN, McNally RK, et al. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg. 1999;188:248-254.
18. Ollila DW, Guilano AE. Intraoperative lymphatic mapping and sentinel lymphadenectomy using isosulfan blue dye. Breast Dis. 1998;8:297-300.
19. Cody HS. Sentinel lymph node mapping in breast cancer. Oncology. 1999;13:25-34.
20. O'Hea BJ, Hill ADK, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg. 1998;186:423-427.
21. Huseh EC, Turner RR, Glass EC, et al. Sentinel node biopsy in breast cancer. J Am Coll Surg. 1999;189:207-213.
22. Guenther JM. Axillary dissection after unsuccessful sentinel lymphadenectomy for breast cancer. Am Surg. 1997;65:991-993.
23. Estourgie SH, Nieweg OE, Valdes Olmos RA, et al. Eight false negative sentinel node procedures in breast cancer: what went wrong? Eur J Surg Oncol. 2003;29:336-340.
24. Estourgie SH, Nieweg OE, Rutgers EJ, et al. What is a false-negative result for sentinel node procedures in breast cancer? J Surg Oncol. 2003;82:141-142.
25. Wong SL, Edwards MJ, Chao C, et al. The effect of lymphatic tumor burden on sentinel lymph node biopsy results. Breast J. 2002;8:192-198.
26. Martin RC, Edwards MJ, Wong SL, et al. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. Surgery. 2000;128:139-144.
27. Noguchi M, Motomura K, Imoto S, et al. A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat. 2000;63:31-40.
28. Olson JA Jr, Fey J, Winawer J, et al. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer. J Am Coll Surg. 2000;191:593-599.
29. Chung MH, Ye W, Giuliano AE. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Ann Surg Oncol. 2001;8:688-692.
30. Wong SL, Chao C, Edwards MJ, et al. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Am Surg. 2001;67: 522-526.
31. Bedrosian I, Reynolds C, Mick R, et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer. 2000;88: 2540-2545.
32. Kem KA. Lymphoscintigraphic anatomy of sentinel lymphatic channels after subareolar injection of Technetium 99m sulfur colloid. J Am Coll Surg. 2001;193:601-608.
33. Smith LF, Cross MJ, Klimberg VS. Subareolar injection is a better technique for sentinel lymph node biopsy. Am J Surg. 2000;180:434-437.
34. McMasters KM, Turtle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560-2566.
35. Radovanovic Z, Golubovic A, Plzak A, et al. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer. Eur J Surg Oncol. 2004;30:913-917.
36. Sardi A, Spiegler E, Colandrea J, et al. The benefit of using two techniques for sentinel lymph node mapping in breast cancer. Am Surg. 2002;68:24-28.
37. Csemi G, Rajtar M, Boross G, et al. Comparison of vital dye-guided lymphatic mapping and dye plus gamma probe-guided sentinel node biopsy in breast cancer. World J Surg. 2002;26:592-597.
38. Motomura K, Inaji H, Komoike Y, et al. Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol. 2001;76:95-99.
39. McMasters KM, Wong SL, Martin RC, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multi-institutional study. Ann Surg. 2001;233:676-687.
40. Jakub JW, Diaz NM, Ebert MD, et al. Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. Am J Surg. 2002;184:302-306.
41. Chu KU, Turner RR, Hansen NM, et al. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol. 1999;6: 756-761.
42. Nos C, Freneaux P, Louis-Sylvestre C, et al. Macroscopic quality control improves the reliability of blue dye-only sentinel lymph node biopsy in breast cancer. Ann Surg Oncol. 2003;10:525-530.
43. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol. 2000;7:636-642.
44. Cox CE, Nguyen K, Gray RJ, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg. 2001;67: 513-521.
45. Tamhane R, Dahlstrom JE, McCallum DD, et al. The clinical significance of cytokeratin-positive cells in lymph nodes at the time of mastectomy from patients with ductal carcinoma-in-situ. Ann Surg Oncol. 2002;9:999-1003.
46. McMasters KM, Chao C, Wong SL, et al. Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal. Cancer. 2002;95: 15-20.
47. Hammond MEH, Fitzgibbons PL, Compton CC, et al. College of American Pathologists Conference XXXV: solid tumor prognostic factors: which, how, and so what? Arch Pathol Lab Med. 2000;124:958-965.
48. Pendas S, Giuliano R, Swor G, et al. Worldwide experience with lymphatic mapping for invasive breast cancer. Semin Oncol. 2004;31: 318-323.
49. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol. 2000; 18:2553-2559.
50. Nano MT, Kollias J, Farshid G, et al. Clinical impact of false-negative sentinel node biopsy in primary breast cancer. Br J Surg. 2002;89:1430-1434.
51. Wong SL, Chao C, Edwards MJ, et al, for the University of Louisville Breast Cancer Study Group. Frequency of sentinel lymph node metastases in patients with favorable breast cancer histologic subtypes. Am J Surg. 2002;184:492-498.